source
- FDA drug division chief Tracy Beth Høeg expected to depart amid leadership shakeupTracy Beth Høeg, who leads the FDA’s Center for Drug Evaluation and Research, is reported to be leaving the agency. Her exit comes shortly after former Commissioner Marty Makary stepped down, sugg…
- Pembrolizumab with BCG shows 92% 6-month complete response in very high-risk T1 bladder cancerA clinical study evaluated the combination of pembrolizumab and bacillus Calmette-Guérin (BCG) in patients with very high-risk T1 non-muscle invasive bladder cancer who had not previously received…